Shares of ImmuPharma plc (LON:IMM – Get Free Report) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 7.63 and traded as low as GBX 4.52. ImmuPharma shares last traded at GBX 4.80, with a volume of 1,804,280 shares changing hands.
ImmuPharma Trading Down 1.1%
The firm has a market capitalization of £29.95 million, a price-to-earnings ratio of -5.39 and a beta of 3.18. The firm has a 50 day moving average price of GBX 6.20 and a two-hundred day moving average price of GBX 7.63.
About ImmuPharma
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Recommended Stories
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
